Nurix Therapeutics, Inc. ($NRIX)
Filing Information
| Accession Number | 0001817199-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 31, 2026 |
| Document Date | Jan 30, 2026 |
| Document | View SEC Filing |
Transactions
10
Total Shares
25,489
Total Value
$73,381.12
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Jan 30, 2026 | Exercise/Conversion | 1,925 | $0.00 | $0.00 | 52,822 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Jan 30, 2026 | Exercise/Conversion | 2,000 | $0.00 | $0.00 | 54,822 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Jan 30, 2026 | Exercise/Conversion | 3,750 | $0.00 | $0.00 | 58,572 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Jan 30, 2026 | Exercise/Conversion | 2,859 | $0.00 | $0.00 | 61,431 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Jan 30, 2026 | Sale | 4,333 | $16.58 | $71,852.41 | 57,098 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Jan 30, 2026 | Sale | 88 | $17.37 | $1,528.71 | 57,010 | Direct | โ | View Details | |
Chief Legal Officer | Restricted Stock Units | Derivative | Jan 30, 2026 | Exercise/Conversion | 1,925 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Legal Officer | Restricted Stock Units | Derivative | Jan 30, 2026 | Exercise/Conversion | 2,000 | $0.00 | $0.00 | 2,000 | Direct | โ | View Details | |
Chief Legal Officer | Restricted Stock Units | Derivative | Jan 30, 2026 | Exercise/Conversion | 3,750 | $0.00 | $0.00 | 18,750 | Direct | โ | View Details | |
Chief Legal Officer | Restricted Stock Units | Derivative | Jan 30, 2026 | Exercise/Conversion | 2,859 | $0.00 | $0.00 | 25,725 | Direct | โ | View Details |